STOCKSCREENR
Log In

ONCY

NASDAQ

Oncolytics Biotech Inc.

$0.99-0.01(-0.92%)Mkt Cap: $99.44M

Key Stats

Market Cap

$99.44M

P/E Ratio

-3.42

EPS

$-0.29

Dividend Yield

0.00%

52-Week Range

$0.33 — $1.51

Volume

362.90K

Avg Volume

1.34M

Beta

0.88

Valuation

P/E (TTM)

-3.42

Forward P/E

—

PEG Ratio

0.72

P/S (TTM)

0.00

P/B (TTM)

1188.28

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-7.55%

ROA (TTM)

-2.34%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

7.26

Current Ratio

1.84

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.06%

EPS Growth (5Y)

+0.18%

Sales Growth (3Y)

+0.00%

Sales Growth (5Y)

+0.00%

EPS Est (This Year)

$-0.34

EPS Est (Next Year)

$-0.31

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.12

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

100.36M

Float

98.50M

Free Float %

98.14%

About

Sector

Healthcare

Industry

Biotechnology

Country

CA

Exchange

NASDAQ

IPO Date

2001-10-05

Employees

28

CEO

Jared Kelly

Index Membership

—

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc. (ONCY) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $99.44M, a P/E ratio of -3.42, ONCY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ONCY against other stocks using dozens of fundamental and technical filters.

Similar Stocks

CYBN

Cybin Inc.

$8.28

+1.22%

$413.02M

FRX.TO

Fennec Pharmaceuticals Inc.

$10.72

-0.05%

$295.33M

OBI.L

Ondine Biomedical Inc.

$11.00

+0.00%

$47.11M

LXEO

Lexeo Therapeutics, Inc. Common Stock

$6.38

-2.89%

$465.66M

IMMP

Immutep Limited

$0.41

-12.96%

$59.61M

MNPR

Monopar Therapeutics Inc.

$60.27

-2.05%

$402.76M

Frequently Asked Questions

What is Oncolytics Biotech Inc.'s P/E ratio?

Oncolytics Biotech Inc. (ONCY) has a trailing twelve-month (TTM) P/E ratio of -3.42. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Oncolytics Biotech Inc. pay a dividend?

No, Oncolytics Biotech Inc. (ONCY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Oncolytics Biotech Inc.'s market cap?

Oncolytics Biotech Inc. (ONCY) has a market capitalization of $99.44 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.